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Background 
Trauma-induced coagulopathy (TIC) is a disorder of the coagulation pathway that occurs 
following a major trauma and is associated with increased mortality and morbidity.<1> 
Thromboelastography (TEG) is one method of assessing for TIC. Studies have suggested that 
TEG can identify TIC and may be useful for predicting blood-component transfusion.<2-4> 
TEG6s (Haemonetics®) is a cartridge-based system which the company claims is more 
reproducible compared to previous models.  
Trauma resuscitations, normally activated by the ambulance service as per their guidelines, 
within St George’s hospital are led by emergency department (ED) consultants or registrars 
as the trauma team leader (TTL). If major haemorrhage is suspected, either on arrival in 
hospital or pre-hospital, a “code red” trauma is activated, allowing immediate access to blood 
products; the TTL guides any blood components which are transfused according to the TTL 
request. The kaolin activated TEG assay, included in the hospital’s guidelines, uses the TEG 
5000 machines (Haemonetics®) situated in intensive care and is rarely performed. ED staff’s 
understanding and knowledge of TIC and TEG is unclear. 
This study aimed to qualitatively establish the reasons TEG is not currently utilised and the 
ongoing practicalities in performing a TEG sample within the resuscitation room of an 
Emergency Department of one London Major Trauma Centre.   
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Methods 
This pilot study was carried out at one London Major Trauma Centre. A trial period was 
arranged for a TEG6s to be placed within the resuscitation room to assess utilisation of TEG; 
there was no obligation to purchase. 
All ED staff were made aware of the TEG6s with demonstrations on its use at the start of the 
trial. Staff were encouraged to run a TEG sample on any code red patient who attended 
during the trial period (December 2016-Janaury 2017 inclusive). The results were available to 
the TTL to use as they felt appropriate (as would have been the case if a TEG sample had 
been run elsewhere).  
Prior to the introduction of the TEG machine, a questionnaire was distributed by hand to 
doctors and nurses within the ED to establish current knowledge around TEG. The 
questionnaire was distributed over the course of several days by one author to ensure suitable 
representation of ED staff (approximately 50% of staff employed in the ED at that time). 
Following the trial, all staff who had run a TEG sample during the trial were contacted for 
their feedback via an online questionnaire (contact details were recorded at the time of 
running the TEG). A second questionnaire was distributed within the ED asking for the wider 
staff’s opinion on the use of TEG in the same manner as the initial questionnaire; staff 
initially surveyed were re-surveyed where possible. (Questionnaires in Appendix 1). 
Ethical approval was not required as there was no change in current practice or the 
established code red protocol (Appendix 2).<5> Data were recorded and analysed in 
Microsoft Excel 2016 and handled in keeping with information governance regulations.   
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Results 
During the trial, there were 16 code red activations. A TEG sample was performed in 75% of 
cases, with one sample being unsuccessful (69% success rate overall - Appendix 3). The 
results relating to pre-trial TEG awareness are demonstrated in Table 1. Of the five members 
of staff who utilised a TEG6s during the trial, all managed to peform the TEG6s successfully 
and stated they found it easy to use. (One person who ran a TEG6s could not be contacted; 
this related to the unsuccessful sample). Blood components for one patient were prescribed 
based on the TEG result.  Following the trial period, the results relating to the TEG machine 
and knowledge surrounding it in the ED are shown in Table 1. 
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Table 1: Knowledge relating to TIC and TEG 
Staff Role Number 
of Staff 
Pre-trial 
Number 
who had 
heard of 
TIC pre-
trial 
Number who 
understand 
what TIC is 
pre-trial 
Number 
of staff 
who heard 
of TEG 
pre-trial 
Number 
of Staff 
Post-trial 
Number of staff 
who felt TEG 
could be utilised 
in the 
resuscitation 
room post-trial 
Number of 
staff who felt 
confident in 
interpreting 
TEG results 
post-trial 
Number of staff 
that felt TEG 
results would 
guide blood 
component 
management 
based on their 
current 
knowledge post-
trial 
Band 5 nurse 20 8 7 5 16 16 3 7 
Band 6 nurse 6 6  6 6 8 8 2 5 
Band 7 nurse 3 1 0 1 3 3 1 0 
Medical 
Assistant 
4 1 0 2 2 1 0 0 
Matron 1 1 1 0 0 N/A N/A N/A 
Senior House 
Officer* 
17 12 8 6 7 7 1 3 
Registrar 4 4 4 4 10 10 6 8 
Consultant 3 3 3 3 6 6 2 4 
Total 58 36 (62%) 29 (50%) 27 (47%) 52 51 (98%) 15 (29%) 27 (52%) 
*Senior House Officer includes Foundation Year 2 (F2), clinical fellow and core trainees; F2 doctors are in their second year after qualifying from medical school; core 
trainees have chosen specialist training in emergency medicine. Registrars have completed their initial emergency medicine examinations (within the UK Membership of the 
Royal College of Emergency Medicine). Band 5 nurses are nurse that have completed their initial nursing qualification. Band 6 and 7 nurses are more senior nurses. 
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Discussion 
This study demonstrated that it is possible to run TEG6s samples within an ED but there is a 
lack of education relating to TIC and the interpretation of TEG results; this is an important 
barrier to TEG utilisation and is likely to hinder its impact on personalising blood component 
management.  
Only one patient had their blood component management altered due to the TEG result as 
there was a lack of confidence amongst clinicians in interpreting results; only 8 of 16 
consultants and registrars surveyed felt confident in interpreting TEG results.  This is 
consistent with a study which found only 11% of doctors correctly estimated the number of 
patients with TIC.<6> Our work is also similar to another investigation that concluded 
emergency physicians lack core knowledge about the use of blood and blood components in 
the context of major haemorrhage following trauma.<7> It would therefore appear that more 
research into how best to educate staff on the use, value and interpretation of  TEG is 
required. Unless this is performed we are unlikely to see TEG results being used to guide 
blood-component transfusion as the literature states it has the potential to.<3, 8> 
Limitations 
This study was based at one London Major Trauma Centre only and may not reflect the 
findings of other centres. However, the majority of doctors included will have worked at 
other EDs in the UK and abroad and so results may not be dissimilar in other centres. There 
was also only a limited number of staff who were required to run a TEG during the trial 
period, which may limit its generalisability; however, it may be that the same staff 
consistently run a TEG as a result of the trauma team protocol.  
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Conclusion 
Viscoelastic haemostatic assays, in particular TEG6s, are likely to be useful in guiding blood 
component support in a timely manner during the initial resuscitation phase of a trauma 
patient. However, considerable education is required to make practical use of the TEG result. 
Until knowledge regarding TEG and its interpretation becomes more widespread, then TEG, 
or indeed similar point-of-care testing, is unlikely to be utilised to fully benefit patients. 
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Appendix 1 
 
Figure 1: Pre-Trial Questionnaire 
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Figure 2: Post trial questionnaire 
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Appendix 2 
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Appendix 3 
Table 1: Results of TEG-6 run during the trial period on Code Red Patients 
Patient Sex Age  Injury 
Severity 
Score 
Number 
of 
TEGS 
run 
TEG results INR 
result 
Blood 
components 
given* 
On review of 
TEG results 
by consultant 
haematologist 
following trial, 
could blood 
product 
administration 
have been 
altered at the 
time of the 
TEG? 
Patient 
Outcome 
1 F 80 22 1 Normal 1.0 3 PRC/2 
FFP 
No Survived 
2 M 28 9 1 Mildly 
hypercoagulable 
1.1 Not 
available  
No Survived 
3 M 51 17 1 Normal 0.9 0 No Survived 
4 M 94 29 1 Test failed 1.0 4 PRC/4FFP No Deceased  
5 M 82 N/A
¶ 
1 Normal NO 
RESULTS 
2 PRC No Deceased 
6 M 26 Awaiting  1 Normal 0.9 1 PRC No Survived 
7 F 92 34 1 Mildly 
hypercoagulable 
1.0 1 PRC No Deceased 
8 F 86 22 1 Mild 
coagulopathy 
1.1 4 PRC/2 
FFP  
Advise plasma  Deceased 
9 M 16 35 1 Coagulopathic 1.4 4 PRC/4FFP Advise 
fibrinogen 
replacement  
Survived 
10 M 46 9 1 Normal 1.1 (initial 
result was 
no result) 
3PRC/3FFP No Deceased 
11 M 33 43 2 Coagulopathic 1.2 4 
PRC/3FFP/1 
Plts/2 cryo 
Advise further 
fibrinogen 
replacement** 
Deceased 
12 M 61 66 1 Coagulopathic 1.3 4PRC/4FFP Advise 
fibrinogen 
replacement 
Deceased 
PRC = packed red cells; FFP = fresh frozen plasma; cryo = cryoprecipitate; Plts = platelets 
*Blood components administered within the emergency department. Some patients went on to have further 
components. 
¶
Patient had a road traffic accident secondary to abdominal aortic aneurysm so no severity of trauma score. No 
blood results formally taken. 
**Patient’s blood components were guided by results of first TEG. Second TEG result suggested fibrinogen 
deficiency. 
 
